Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q1 2026 · 10-Q
Revenue$204.58M$204.58M+1.6% vs Q1 2025 Net Income-$11.29M-$11.29MN/M vs Q1 2025 EPS Diluted-$0.39-$0.39N/M vs Q1 2025 Gross Profit$176,912,000+3.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flow$12,849,000N/M Free Cash Flowderived$3,123,000N/M Margins · derivedGross margin86.5%+1.7 pt vs Q1 2025
Operating margin-0.5%+0.2 pt vs Q1 2025
Net margin-5.5%−7.0 pt vs Q1 2025
ended Mar 31, 2026 · filed May 4, 2026 · 34 d after period end